Zheng Yang Biomedical Technology

Zheng Yang Biomedical Technology focuses on regenerative medicine, particularly platelet-derived biological therapies for dry eye syndrome and related ophthalmic indications. The company has a collaboration with Cambium Bio for clinical development and has a strong presence in Taiwan’s dental and oral health sector through its Dr. Wells dental clinic chain. Clinical results are not widely published in the international literature, but its lead product, Aurarix™ (based on human platelet lysate), is in clinical development for moderate-to-severe dry eye syndrome, with Cambium Bio having received a FDA clinical letter for its related product, Elate Ocular®[5][6].